(NaturalNews) The pharmaceutical industry is generally known to be a greed-driven, profiteering racket. However, the real danger for average Americans isn’t just getting ripped off while suffering horrific side effects as a result of taking drugs — it’s the threat of going bankrupt simply due to having a chronic illness for which the medical-industrial complex now prescribes “cures” that cost upwards of tens of thousands of dollars to manage.

Pharmaceutical Industry is for Pure Profit Only.

It is a shame. No it is an outrage that the entire pharmaceutical industry could care less about you, or your disease. They only thing that they really care about is the bottom line. And cancer treatment provides them the greatest profit of all.

This article will look at 3 potentially life saving cancer treatments. The costs for treatment? Chances are, you will not have enough money in your savings account to cover the cost.

Natural News

Oh, the tragic irony: These

Cancer is arguably the biggest profiteering disease of all. It’s the one condition that will never have a cure — at least, that you’ll hear about in the mainstream media — and will perpetually be assigned “experimental” treatments that would drain your entire bank account in a year or less. Here’s an overview of some of these so-called experimental drugs and the costs associated with each:

1. Portrazza (necitumumab) by Eli Lilly & Co.
This experimental lung cancer drug doesn’t cure lung cancer, of course, but its manufacturer claims that when combined with chemotherapy, it might help extend a patient’s lifespan by a mere month and a half. The cost? As much as $1,309 per three-week cycle, according to The Washington Post. This translates to a cost of more than $22,500 annually.

2. Provenge (sipuleucel-T) by Dendreon
The sad truth is that necitumumab is actually on the lower end of the cancer drug-pricing spectrum. Cancer drugs like Provenge (sipuleucel-T), which is used to treat prostate cancer, cost far more. This FDA-approved cancer drug reportedly costs about $93,000 per year, and only increases one’s lifespan by about four months, on average.

3. Adcetris (brentuximab) by Seattle Genetics
Adcetris, a drug used to treat Hodgkin’s lymphoma, costs about $16,000 a shot! Honestly, who can actually afford this? While some have reported positive results thanks to Adcetris, the cost of a single shot alone is worth more than what an average American family earns in a month. Sure, you’d see some improvements — but how will you and your family survive with all the debt piling up?

Read the full article on Natural News